Home › Core › ISCC-IDs › 28CrZQWeQBH3d

View ISCC-ID

Core Data

28CrZQWeQBH3d
ISCC-ID - digital asset identifier
CCfnHuQ3Pa9CS-CTExJ5HUG4Vm9-CDhrm98491o77-CRfKYSsr2fj8w
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

gastroesophageal reflux disease symptom severity proton pump inhibitor use and esophageal carcinogenesis

Ledger Reference

coblo
Source Ledger/Blockchain
664815
N-th ISCC Decleration on source ledger
39d76f9caefe701ae8ebff19ad200733e4075fff0ba430f6a9e5e604f0023a57
Hash of block that includes the ISCC-DECLARATION
332b3d2dca6fd6089e36b23f802f6d1ac53e77d8bc541ae87ff813edb50fd4f7
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Gastroesophageal Reflux Disease Symptom Severity, Proton Pump Inhibitor Use, and Esophageal Carcinogenesis", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Katie S. Nason", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://europepmc.org/articles/pmc4086744?pdf=render", "encodingFormat": "application/pdf"}], "publisher": {"name": "American Medical Association (AMA)", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1001/archsurg.2011.174", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCfnHuQ3Pa9CS-CTExJ5HUG4Vm9-CDhrm98491o77-CRfKYSsr2fj8w", "propertyID": "ISCC"}], "datePublished": "2011-07-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close